Breaking News
February 20, 2019 - Newly licensed nurses work for long hours, also have a second paid job
February 20, 2019 - Physicists identify simple mechanism used by deadly bacteria to fend off antibiotics
February 20, 2019 - FDA Grants Priority Review to Genentech’s Personalized Medicine Entrectinib
February 20, 2019 - Exposure to chemicals before and after birth is associated with a decrease in lung function
February 20, 2019 - Neuroscientists reveal that simple brain region can guide complex feats of mental activity
February 20, 2019 - Study finds new link between food allergies and multiple sclerosis
February 20, 2019 - First gene therapy operation for macular degeneration is a success
February 20, 2019 - Physicians graduated outside the U.S. offer better care for Medicare patients with complex needs
February 20, 2019 - FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
February 20, 2019 - Study identifies brain cells that modulate behavioral response to threats
February 20, 2019 - Researchers take closer look at how viruses bind cells and cause infection
February 20, 2019 - Newly developed gene therapy helps decelerate aging process
February 20, 2019 - Study suggests new treatment strategy for deadly brain cancer
February 20, 2019 - Scientists develop unique hybrid implant that imitates bone structure
February 20, 2019 - Push-ups can be tailored to meet specific needs of individuals
February 20, 2019 - CVD Does Not Modify Depression-Mortality Link in Elderly
February 20, 2019 - Electrical activity early in fruit flies’ brain development could shed light on how neurons wire the brain
February 20, 2019 - Machine learning technique helps predict which asthma patients respond to corticosteroid therapy
February 20, 2019 - Self-reported sleep duration is a useful tool to measure sleep in children, study suggests
February 20, 2019 - T-cells play key role in how the body fights follicular lymphoma
February 20, 2019 - Study shows how 3D organization of genetic material helps perpetuate the species
February 20, 2019 - Researchers engineer stem cell with ‘suicide genes’ to induce cell death in all but beta cells
February 20, 2019 - Study reveals major sex differences in management of cardiovascular risk factors among U.S. adults
February 20, 2019 - Health Tip: Get Your Child to School on Time
February 20, 2019 - Shortcut strategy for screening compounds with clinical potentials for drug development
February 20, 2019 - Common acid reflux drugs tied to elevated risk for kidney disease
February 20, 2019 - Microbiome could be culprit when good drugs do harm
February 20, 2019 - Prenatal exposure to forest fires causes stunted growth in children
February 20, 2019 - Gene therapy restores hearing in mice with congenital genetic deafness
February 20, 2019 - First molecular test predicts treatment response for kidney cancer
February 20, 2019 - New method for improved visualization of single-cell RNA- sequencing data
February 20, 2019 - Researchers capture altered brain activity patterns of Parkinson’s in mice
February 20, 2019 - A possible blood test for detecting Alzheimer’s disease before symptoms show
February 20, 2019 - Primary care physicians associated with longevity, new research finds
February 19, 2019 - New study identifies many key lessons to establish sanctioned safe consumption sites
February 19, 2019 - Single CRISPR treatment can safely and stably correct genetic disease
February 19, 2019 - Multinational initiative to study familial primary distal renal tubular acidosis
February 19, 2019 - Breakthrough study highlights the promise of cell therapies for muscular dystrophy
February 19, 2019 - Subsymptom Threshold Exercise Speeds Concussion Recovery
February 19, 2019 - Midline venous catheters – infants: MedlinePlus Medical Encyclopedia
February 19, 2019 - Searching for side effects
February 19, 2019 - Humanity is all right, probably, although human extinction remains quite possible, researcher says
February 19, 2019 - Having Anesthesia Once as a Baby Does Not Cause Learning Disabilities, New Research Shows
February 19, 2019 - Anti-cancer immunotherapy could be used to fight HIV
February 19, 2019 - Customized Micropatterning for Improved Physiological Relevance
February 19, 2019 - Unique gene therapy approach paves new way to tackle rare, inherited diseases
February 19, 2019 - Activating gene that helps excite neurons reverses depression in male mice
February 19, 2019 - Science Puzzling Out Differences in Gut Bacteria Around the World
February 19, 2019 - Cells that destroy the intestine
February 19, 2019 - On recovery, vulnerability and ritual: An exhibit in white
February 19, 2019 - Scientific Duo Gets Back To Basics To Make Childbirth Safer
February 19, 2019 - COPD patients need more support when understanding new chest symptoms
February 19, 2019 - Using light-based method for production of pharmaceutical molecules
February 19, 2019 - Scientists find link between inflammation and cancer
February 19, 2019 - The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
February 19, 2019 - Hearing impairment associated with accelerated cognitive decline with age
February 19, 2019 - Researchers identify multiple genetic variants associated with body fat distribution
February 19, 2019 - Influenza and common cold are completely different diseases, study shows
February 19, 2019 - Scientists untangle how microbes manufacture key antibiotic compound
February 19, 2019 - Greater primary care physician supply associated with longer life spans
February 19, 2019 - HIV-1 protein suppresses immune response more broadly than thought
February 19, 2019 - Brain imaging indicates potential success of drug therapy in depressive patients
February 19, 2019 - For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
February 19, 2019 - Specialized lung cells appear in the developing fetus much earlier than previously thought
February 19, 2019 - KU professor discusses promise of brain-computer interface to aid, restore communication
February 19, 2019 - Highly effective solution for detecting onset of aggregation in nanoparticles
February 19, 2019 - Early marker of cardiac damage triggered by cancer treatment identified
February 19, 2019 - Antidepressant drug could save people from deadly sepsis, research suggests
February 19, 2019 - CRISPR technology creates pluripotent stem cells that are ‘invisible’ to the immune system
February 19, 2019 - New study establishes how stress favors breast cancer growth and spread
February 19, 2019 - Midlife Systemic Inflammation Linked to Later Cognitive Decline
February 19, 2019 - Therapy derived from parasitic worms downregulates proinflammatory pathways
February 19, 2019 - Antimicrobial reusable coffee cups are less likely to become contaminated with bacteria, study shows
February 19, 2019 - Harnessing the evolutionary games played by cancer cells to advance therapies
February 19, 2019 - AHA News: Heart Transplant Survivor Gets Wedding Proposal at Finish Line
February 19, 2019 - HIV hidden in patients’ cells can now be accurately measured
February 19, 2019 - Research finds reasons for sudden cardiac death in patients with stable ischemic disease
February 19, 2019 - New protocol could help physicians to rule out bacterial infections in infants
February 19, 2019 - Women experiencing miscarriage should be offered treatment choices
February 19, 2019 - New protocol can help identify febrile infants at low risk for serious bacterial infections
Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible

Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible

image_pdfDownload PDFimage_print

WEDNESDAY, Nov. 14, 2018 — People with celiac disease must follow a very restrictive diet, but an experimental vaccine may offer many of them the freedom to eat more normally.

Celiac disease is an autoimmune disorder. If someone with the disease eats gluten — a protein found in wheat, barley and rye — it can damage the small intestine.

The vaccine, dubbed Nexvax2, is designed to elicit an immune system response in about 90 percent of people with celiac disease — specifically those who carry a gene that allows their immune system to “see” the vaccine.

“People with celiac disease often are afraid of food. Nexvax2 will give them freedom to be able to live life and not be afraid of eating out. It will be socially liberating,” said Leslie Williams, CEO of ImmusanT, the company developing the vaccine.

Eating a gluten-free diet isn’t easy, according to Alice Bast, CEO of Beyond Celiac, a nonprofit research organization. Cross contamination with foods containing gluten is always a concern, she explained.

“Because people with celiac disease note that their toughest challenges are when dining out, socializing and traveling, an effective treatment could bring back some of the freedoms people in our community have lost,” Bast said.

“If [Nexvax2] is effective, it may one day be used to enable people with celiac disease to eat a normal diet that contains gluten without damaging their system or getting sick,” she said.

About 1 percent of Americans have celiac disease. Symptoms include stomach pain and bloating, diarrhea, vomiting, constipation, weight loss, fatigue, and delayed growth and puberty. Long-term problems can include malnutrition and nervous system problems.

The current treatment is avoiding gluten. But gluten is found in many foods and products such as lipstick. Even foods that don’t directly contain gluten may be contaminated by gluten during the production process. Something as simple as a gluten-free chicken cutlet being fried in a pan previously used to cook a breaded (containing gluten) chicken cutlet may cause damage to someone with celiac disease, Bast explained.

Williams said that inadvertent gluten exposures like that occur an average of three to four times a month.

Nexvax2 works by reprogramming the T cells in the immune system that attack the small intestine in people with celiac disease. The injectable vaccine makes these cells nonresponsive to gluten exposure, Williams said.

The maintenance injections can be given at home with a device that automatically injects the vaccine under the skin. Williams said people would likely need to give themselves a shot once a week to protect themselves from inadvertent gluten exposures.

ImmusanT has completed five phase 1 trials of Nexvax2, Williams said. Early trials caused patients to vomit, so the initial vaccine dose was lowered. Then it’s slowly increased until people are exposed to an amount of gluten that’s about equivalent to two loaves of bread.

Williams said the vaccine was safe and well-tolerated in the early trials. Because it affects a specific part of the immune system, she said there aren’t concerns about immune system suppression.

“The vaccine targets only the part of the immune system that leads to celiac disease complications throughout the body. Unlike immunotherapy treatments for cancer, rheumatoid arthritis and inflammatory bowel disease, Nexvax2 does not suppress the whole immune system,” Bast said.

ImmusanT is planning a six-month phase 2 study on the vaccine. It will include 150 people with celiac disease from 40 sites in the United States, Australia and New Zealand, Williams noted. She said it’s too soon to predict right now when the vaccine might potentially be available. It’s also too soon to estimate the cost, she said.

Bast said that Nexvax2 isn’t the only possible treatment for celiac disease in development.

“There are more than a dozen therapies in the research pipeline. Nexvax2 is one of three therapeutic vaccines under investigation. Other approaches include preventing gluten from being absorbed by the body, breaking the gluten down using enzymes, and managing the body’s reaction to gluten after it is absorbed,” Bast said.

More information

The Celiac Disease Foundation offers more on celiac disease.

© 2018 HealthDay. All rights reserved.

Posted: November 2018

Tagged with:

About author

Related Articles